About LifeSprout
LifeSprout is a company based in Baltimore (United States) founded in 2015 by Justin Sacks, Sashank Reddy, Russell Martin, Mohamed Benjelloun, and Hai-Quan Mao. LifeSprout has raised $44.7 million across 5 funding rounds from investors including Maryland.gov, Medytox and TEDCO. The company has 12 employees as of December 31, 2022. LifeSprout offers products and services including Tissue Restoration Platform and Regenerative Medicine Suite. LifeSprout operates in a competitive market with competitors including Augmenix, AmacaThera, Regentis Biomaterials, Carbylan and Biosyntech, among others.
- Headquarter Baltimore, United States
- Employees 12 as on 31 Dec, 2022
- Founders Justin Sacks, Sashank Reddy, Russell Martin, Mohamed Benjelloun, Hai-Quan Mao
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lifesprout, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$44.7 M (USD)
in 5 rounds
-
Latest Funding Round
$28.5 M (USD), Series A
Apr 21, 2020
-
Investors
Maryland.gov
& 9 more
-
Employee Count
12
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of LifeSprout
LifeSprout offers a comprehensive portfolio of products and services, including Tissue Restoration Platform and Regenerative Medicine Suite.
Products that mimic body tissues for soft tissue restoration purposes
Suite of products for enhancing form and function in patients
People of LifeSprout
Unlock access to complete
Funding Insights of LifeSprout
LifeSprout has successfully raised a total of $44.7M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $28.5 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $28.5M
-
First Round
First Round
(21 Feb 2018)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2020 | Amount | Series A - LifeSprout | Valuation | Redmile Group | |
| May, 2019 | Amount | Series A - LifeSprout | Valuation | Kairos Ventures , TEDCO |
|
| Jun, 2018 | Amount | Series A - LifeSprout | Valuation | Kairos Ventures , Triskelion Capital |
Investors in LifeSprout
LifeSprout has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include Maryland.gov, Medytox and TEDCO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments are provided by Emerald.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life sciences, physical sciences, and technology companies
|
Founded Year | Domain | Location | |
|
Venture capital fund and startup accelerator programs focused on seed and early stage companies
|
Founded Year | Domain | Location |
Investments & Acquisitions by LifeSprout
Financial Statements - LifeSprout
Lifesprout Comparisons
Competitors of LifeSprout
LifeSprout operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmenix, AmacaThera, Regentis Biomaterials, Carbylan and Biosyntech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hydrogel spacers are provided for prostate cancer radiation therapy.
|
|
| domain | founded_year | HQ Location |
Injectable hydrogel platform developed for therapeutic medical applications.
|
|
| domain | founded_year | HQ Location |
Regentis Biomaterials is focused on tissue repair hydrogel technology.
|
|
| domain | founded_year | HQ Location |
Hyaluronic acid polymers are developed into therapeutics for pain management.
|
|
| domain | founded_year | HQ Location |
Biotherapeutic thermogels are developed for tissue repair applications.
|
Frequently Asked Questions about LifeSprout
LifeSprout was founded in 2015 and raised its 1st funding round 3 years after it was founded.
LifeSprout is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Sashank Reddy is the current CEO of LifeSprout. They have also founded this company.
LifeSprout is a funded company, having raised a total of $44.7M across 5 funding rounds to date. The company's 1st funding round was a Series A of $6.5M, raised on Feb 21, 2018.
As of Dec 31, 2022, the latest employee count at LifeSprout is 12.
LifeSprout was founded in 2015 in Baltimore, United States, within the biotechnology sector focused on tissue engineering. An injectable hydrogel product called Scaffold, composed of biodegradable nanofibers, is offered for applications in cancer reconstruction, trauma repair, and cosmetics. The material occupies space to support tissue growth, permits cell permeability, and dissolves in body fluids. It enables breast reconstruction for mastectomy patients without harvesting tissue from other areas.
LifeSprout's top competitors include AmacaThera, Augmenix and Regentis Biomaterials.
LifeSprout offers Tissue Restoration Platform and Regenerative Medicine Suite.
LifeSprout has 10 investors. Key investors include Maryland.gov, Medytox, TEDCO, Redmile Group, and unknown.